Mandate

Vinge has advised Bilprovningen in connection with the sale of approx. 1/3 of its network of inspection stations

July 09, 2012

Vinge has advised Aktiebolaget Svensk Bilprovning in connection with the disposal of Besiktningskluster 1 AB to Opus Group AB (publ). Besiktningskluster 1 AB owns around 1/3 of Bilprovningen’s network of inspection stations and the disposal is part of the reregulation and competition exposure of the Swedish vehicle inspection market. Opus Group AB (publ) is listed on First North Premier (NASDAQ OMX) and develops, produces and sell products and services for, inter alia, vehicle inspections and repair workshops, and operates mandatory vehicle inspection programs in a number of countries. The purchase price amounts to approx. MSEK 375. The transaction is subject to, inter alia, accreditation approval.

The Vinge team was led by Carl Gustaf De Geer, Daniel Rosvall and Peter Sundgren and included lawyers from a number of practice areas such as M&A, Banking & Finance, EU &Antitrust, IT, Employment & Benefits, Real Estate, Intellectual Property and also entailed regulatory issues regarding the motor vehicle inspection legislation.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025